Susquehanna International Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.04M | Sell |
10,500
-2,700
| -20% | -$1.38M | ﹤0.01% | 4206 |
|
|
2025
Q4 | $7.41M | Sell |
13,200
-17,900
| -58% | -$10.2M | ﹤0.01% | 3454 |
|
|
2025
Q3 | $16M | Buy |
31,100
+15,200
| +96% | +$6.64M | ﹤0.01% | 2440 |
|
|
2025
Q2 | $4.99M | Buy |
15,900
+3,700
| +30% | +$1.11M | ﹤0.01% | 3969 |
|
|
2025
Q1 | $3.72M | Sell |
12,200
-4,300
| -26% | -$1.45M | ﹤0.01% | 4227 |
|
|
2024
Q4 | $5.48M | Buy |
16,500
+5,100
| +45% | +$1.73M | ﹤0.01% | 3452 |
|
|
2024
Q3 | $3.81M | Sell |
11,400
-1,000
| -8% | -$380K | ﹤0.01% | 4104 |
|
|
2024
Q2 | $5.11M | Sell |
12,400
-69,700
| -85% | -$27.6M | ﹤0.01% | 3402 |
|
|
2024
Q1 | $33.2M | Buy |
82,100
+67,000
| +444% | +$23.6M | 0.01% | 1325 |
|
|
2023
Q4 | $4.63M | Sell |
15,100
-3,900
| -21% | -$1.05M | ﹤0.01% | 3835 |
|
|
2023
Q3 | $4.6M | Sell |
19,000
-6,100
| -24% | -$1.56M | ﹤0.01% | 3676 |
|
|
2023
Q2 | $6.03M | Buy |
25,100
+21,100
| +528% | +$4.38M | ﹤0.01% | 3229 |
|
|
2023
Q1 | $752K | Sell |
4,000
-12,900
| -76% | -$2.67M | ﹤0.01% | 7547 |
|
|
2022
Q4 | $3.59M | Sell |
16,900
-41,900
| -71% | -$8.37M | ﹤0.01% | 3743 |
|
|
2022
Q3 | $9.24M | Buy |
58,800
+2,300
| +4% | +$367K | ﹤0.01% | 2267 |
|
|
2022
Q2 | $8.46M | Buy |
56,500
+41,200
| +269% | +$5.96M | ﹤0.01% | 2431 |
|
|
2022
Q1 | $2.5M | Buy |
15,300
+10,900
| +248% | +$1.8M | ﹤0.01% | 4985 |
|
|
2021
Q4 | $958K | Sell |
4,400
-24,500
| -85% | -$5.13M | ﹤0.01% | 7412 |
|
|
2021
Q3 | $5.47M | Sell |
28,900
-3,000
| -9% | -$547K | ﹤0.01% | 3791 |
|
|
2021
Q2 | $5.63M | Buy |
31,900
+20,300
| +175% | +$3.5M | ﹤0.01% | 3824 |
|
|
2021
Q1 | $1.9M | Buy |
11,600
+1,300
| +13% | +$199K | ﹤0.01% | 6047 |
|
|
2020
Q4 | $1.43M | Buy |
10,300
+3,900
| +61% | +$492K | ﹤0.01% | 5842 |
|
|
2020
Q3 | $715K | Sell |
6,400
-4,200
| -40% | -$486K | ﹤0.01% | 6923 |
|
|
2020
Q2 | $986K | Sell |
10,600
-11,800
| -53% | -$1M | ﹤0.01% | 5955 |
|
|
2020
Q1 | $1.64M | Buy |
22,400
+5,700
| +34% | +$495K | ﹤0.01% | 4333 |
|
|
2019
Q4 | $1.4M | Sell |
16,700
-400
| -2% | -$31K | ﹤0.01% | 4909 |
|
|
2019
Q3 | $1.44M | Sell |
17,100
-7,100
| -29% | -$536K | ﹤0.01% | 4912 |
|
|
2019
Q2 | $1.58M | Sell |
24,200
-25,500
| -51% | -$1.47M | ﹤0.01% | 4644 |
|
|
2019
Q1 | $2.93M | Sell |
49,700
-1,200
| -2% | -$71.7K | ﹤0.01% | 3162 |
|
|
2018
Q4 | $2.69M | Buy |
50,900
+7,100
| +16% | +$390K | ﹤0.01% | 3079 |
|
|
2018
Q3 | $2.62M | Buy |
43,800
+32,200
| +278% | +$1.76M | ﹤0.01% | 3569 |
|
|
2018
Q2 | $499K | Sell |
11,600
-3,300
| -22% | -$133K | ﹤0.01% | 6790 |
|
|
2018
Q1 | $520K | Buy |
+14,900
| New | +$544K | ﹤0.01% | 6553 |
|
Other funds holding MEDP
VPM
VCM
WA
Susquehanna International Group's MEDP Position: Q1 2026 in Review
Susquehanna International Group reduced its Medpace (MEDP) stake by 77% in Q1 2026, selling an estimated $1.72M and leaving 978 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #9837.
Susquehanna International Group first reported a position in MEDP in Q2 2017 and has held it in 31 quarters since. The position peaked at $35.1M in Q2 2023. 731 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- Susquehanna International Group held 978 shares of Medpace worth $470K as of Q1 2026.
- Susquehanna International Group sold 3,354 Medpace shares in Q1 2026, an estimated $1.72M.
- Medpace made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9837 holding.
- Susquehanna International Group first reported a position in Medpace in Q2 2017 and has held it in 31 quarters since.
- Susquehanna International Group's Medpace position peaked at $35.1M in Q2 2023.
- 731 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.